Charles joined Cerba HealthCare in 2015.

Previoulsy, he managed the Novescia Loire group of clinical pathology laboratories.

Charles holds a PhD in Medicine, a Post-Graduate Degree in clinical pathology and a MBA from EM Lyon.

Laurent joined Cerba HealthCare in 2015.

Previously, he managed a group of clinical pathology laboratories in Occitanie. Laurent holds a PhD in pharmacology, a Post-Graduate Degree in clinical pathology, a degree in Medically Assisted Procreation and a MBA from EM Lyon.

Stéphane joined Ketterthill in 2008. 

He has more than 20 years of experience in clinical pathology. 

He previously served as Chief of Haematology Department at Military Hospital Legouest, Metz. 

Stéphane holds a Doctor in Pharmacy and was awarded a MBA from EM Lyon. 

Dr Nuala Murphy was appointed to the board of Cerba HealthCare in 2023, in addition to assuming the chair of the ESG committee and executive chair of Cerba Research. 

With a background in drug development, Nuala is a strategic advisor to private equity, having held leadership & board roles in the pharmaceutical sector, most recently as President of Drug development and Commercialization at ICON Plc. 

Nuala graduated from Trinity College Dublin, was awarded a PhD from the School of Medicine at the University of Leeds, a post-doctorate in neuroscience from the Collège de France, Paris, a diploma in ESG from the Corporate Governance Institute and was certified in corporate governance at INSEAD.

Aurélie joined Cerba HealthCare in 2015. 

Prior to becoming CEO of Cerba in 2022, Aurélie was President of Cerballiance South Paris Region, and then Head of Asia Pacific and Global Lead of Laboratory Partnership for Cerba Research.

Aurélie is a Doctor of Pharmacy and graduated from EM Lyon business school. 

Philippe joined Cerba HealthCare in 2011.

He previously served as General Manager for the south of France region at Générale de Santé Group.

Philippe received a degree from the University Paris X and an Executive Management degree from HEC.

Paul joined Cerba HealthCare in 2023.

Paul spent 30 years in management positions at Procter & Gamble, Allergan (President) and Ferring Inc (CEO).

He is currently a member of the board of directors of several companies around the world (LEO Pharma, HTL, Hallura) and advises private equity funds.

He is acting as CEO ad interim for Cerba HealthCare and Chairman of the Board.

Paul graduated from Institut Supérieur de Commerce business school, and INSEAD in corporate governance.

Stéphane a rejoint Cerba HealthCare en 2017 . 

Il bénéficie de plus de 20 ans d’expérience dans la direction de filiales internationales de sociétés spécialisées dans les services aux entreprises. 

Stéphane est titulaire d’un Master de l’École de commerce de Paris.